title: Split-liver transplantation. The Paul Brousse policy.
abstract: OBJECTIVE
  The authors objective is to report their recent experience with split-liver transplantation, focusing on the results and the impact on organ shortage.
  
  
  BACKGROUND
  There is an insufficient number of organs for liver transplantation. Split-liver transplantation is a method to increase the number of grafts, but the procedure is slow to gain wide acceptance because of its complexity and the poor results reported in previous series.
  
  
  METHODS
  During the year 1995, the authors split 20 of 83 transplantable livers allocated to the authors' center, generating 40 grafts: 23 were transplanted locally and 17 were given to partner centers. During the same period, the authors accepted four split-liver grafts proposed to them by other centers. Overall, 27 split-liver transplantations were done in the authors' unit, accounting for 30% of the 90 transplants performed in 1995.
  
  
  RESULTS
  One-year patient and graft survival rates for split-liver transplantation were 79.4% and 78.5%, respectively. Arterial and biliary complications rates were 15% and 22%, respectively, with none leading to graft loss. Primary nonfunction occurred in one case (4%). By splitting 24 of 87 transplantable livers (4 of which were in partner units), a total of 111 transplantations were performed, increasing graft availability by 28%.
  
  
  CONCLUSIONS
  Split-liver transplantation is achieving graft and patient survival rates similar to that of whole liver transplantation despite a higher incidence of complications, which could become less frequent as experience is gained with this procedure. A wider acceptance of split-liver transplantation could markedly increase the supply of liver grafts.
authors.affiliation: Hepatobiliary Surgery and Liver Transplant Center, Hôpital Paul Brousse, Université Paris Sud, Villejuif, France.
authors.forename: D
authors.initials: D
authors.lastname: Azoulay
authors.forename: I
authors.initials: I
authors.lastname: Astarcioglu
authors.forename: H
authors.initials: H
authors.lastname: Bismuth
authors.forename: D
authors.initials: D
authors.lastname: Castaing
authors.forename: P
authors.initials: P
authors.lastname: Majno
authors.forename: R
authors.initials: R
authors.lastname: Adam
authors.forename: M
authors.initials: M
authors.lastname: Johann
mesh_terms: D000328:Adult; D005260:Female; D006085:Graft Survival; D006499:Hepatic Artery / Q000033:anatomy & histology; D006501:Hepatic Encephalopathy / Q000601:surgery*; D006801:Humans; D007223:Infant; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011169:Portal Vein / Q000033:anatomy & histology; D011183:Postoperative Complications; D009927:Tissue and Organ Procurement; D016896:Treatment Outcome; D014654:Vascular Patency; D014656:Vascular Surgical Procedures / Q000009:adverse effects